Autonomize AI Secures $28 Million to Improve Healthcare Efficiency
Autonomize AI, a company specializing in AI-driven healthcare solutions, has raised $28 million in a recent funding round. The investment was led by Valtruis, The Cigna Group Ventures, and Tau Ventures, with additional contributions from existing backers including Asset Management Ventures, ATX Venture Partners, and Capital Factory. This funding brings the company’s total capital to $32 million.
The new funds will be used to advance Autonomize AI's agentic AI orchestration platform. This platform aims to reduce the administrative workload for healthcare professionals and enhance the overall patient experience by streamlining care processes.
Addressing Healthcare Challenges with Human-Centered AI
Ganesh Padmanabhan, CEO of Autonomize AI, emphasized that the current healthcare system struggles to meet the demands of modern care delivery. He pointed out that delays, wasted time, and unnecessary friction affect both patients and clinicians. According to him, automation alone doesn’t solve these issues—what’s needed is accountable, human-centered AI augmentation that supports healthcare workers effectively.
Proven Impact Since 2022
Since its launch in 2022, Autonomize AI’s technology has generated 100,000 automated care plans. This automation allows providers to focus more on meaningful patient interactions instead of routine administrative tasks. Additionally, the platform has accelerated decisions related to prior authorizations and claims by 50%, helping speed up healthcare delivery and reduce bottlenecks.
Healthcare professionals interested in AI applications that reduce administrative burdens and improve patient outcomes may find the ongoing developments at Autonomize AI worth following.
Your membership also unlocks:
